Literature DB >> 17099090

Pulmonary arterial hypertension: classification, diagnosis and contemporary management.

D J Fox1, R S Khattar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17099090      PMCID： PMC2660498          DOI： 10.1136/pgmj.2006.044941

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  37 in total

Review 1.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

2.  Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man.

Authors:  W Krause; T Krais
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients.

Authors:  P J Currie; J B Seward; K L Chan; D A Fyfe; D J Hagler; D D Mair; G S Reeder; R A Nishimura; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

4.  Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

Authors:  K B Lane; R D Machado; M W Pauciulo; J R Thomson; J A Phillips; J E Loyd; W C Nichols; R C Trembath
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

6.  Perfusion lung scans vs pulmonary angiography in evaluation of suspected primary pulmonary hypertension.

Authors:  A J Fishman; K M Moser; P F Fedullo
Journal:  Chest       Date:  1983-12       Impact factor: 9.410

7.  Primary pulmonary hypertension: natural history and the importance of thrombosis.

Authors:  V Fuster; P M Steele; W D Edwards; B J Gersh; M D McGoon; R L Frye
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

8.  M&B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs.

Authors:  D A Braner; J R Fineman; R Chang; S J Soifer
Journal:  Am J Physiol       Date:  1993-01

9.  Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

Authors:  G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

10.  Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes.

Authors:  I Murata; H Kihara; S Shinohara; K Ito
Journal:  Jpn Circ J       Date:  1992-10
View more
  2 in total

1.  Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.

Authors:  Edward A Pankey; Matthew Epps; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  J Clin Rheumatol Musculoskelet Med       Date:  2010-12-01

2.  Patient-specific finite element analysis of heart failure and the impact of surgical intervention in pulmonary hypertension secondary to mitral valve disease.

Authors:  Alireza Heidari; Khalil I Elkhodary; Cristina Pop; Mohamed Badran; Hojatollah Vali; Yousof M A Abdel-Raouf; Saeed Torbati; Masoud Asgharian; Russell J Steele; Iradj Mahmoudzadeh Kani; Sara Sheibani; Hamidreza Pouraliakbar; Hakimeh Sadeghian; Renzo Cecere; Matthias G W Friedrich; Hossein Ahmadi Tafti
Journal:  Med Biol Eng Comput       Date:  2022-04-20       Impact factor: 2.602
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.